Real-world multicenter study of T-DXd treatment in Chinese patients with metastatic breast cancer

被引：0
作者：
Wang, Biyun [1 ]
Li, Yumeng [1 ]
Zhao, Yannan [1 ]
Sang, Die [2 ]
Yuan, Peng [3 ]
Zhao, Yanxia [4 ]
Lv, Zheng [4 ]
Xie, Ning [5 ]
Li, Nanling [6 ]
Li, Juanjuan [7 ]
Wang, Fang [8 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Beijing Zhongke Sanhuan Hitech Co Ltd, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Tumor Hosp, Beijing, Peoples R China
[4] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan, Peoples R China
[5] Hunan Canc Hosp, Changsha, Hunan, Peoples R China
[6] Xijing Hosp, Xian, Peoples R China
[7] Wuhan Univ, Renmin Hosp, Wuhan, Peoples R China
[8] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
来源：
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2025年 / 55卷
关键词：
breast cancer; real-world effectiveness; trastuzumab deruxtecan; systemic therapy;
D O I：
10.1016/j.lanwpc.2024.101416
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
    Varella, Leticia
    Eziokwu, Akaolisa Samuel
    Jia, Xuefei
    Kruse, Megan
    Moore, Halle C. F.
    Budd, George Thomas
    Abraham, Jame
    Montero, Alberto J.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (02) : 429 - 434
  • [22] Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2-metastatic breast cancer
    Cuyun Carter, Gebra
    Sheffield, Kristin M.
    Gossai, Anala
    Huang, Yu-Jing
    Zhu, Yajun Emily
    Bowman, Lee
    Nash Smyth, Emily
    Mathur, Raina
    Cohen, Aaron B.
    Rasmussen, Erik
    Balakrishna, Shreya
    Morato Guimaraes, Claudia
    Rybowski, Sarah
    Seidman, Andrew D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (07) : 1179 - 1187
  • [23] Study design for DESTINY-Breast Respond HER2-low Europe: T-DXd in patients with HER2-low advanced breast cancer
    Guarneri, Valentina
    Coelho, Jose Luis Passos
    Duhoux, Francois P.
    Egle, Daniel
    Garcia-Saenz, Jose angel
    Penault-Llorca, Frederique
    Selander, Katri
    Wildiers, Hans
    Zaman, Khalil
    Laeis, Petra
    Lucerna, Markus
    Pierga, Jean-Yves
    FUTURE ONCOLOGY, 2024, 20 (18) : 1237 - 1250
  • [24] Real-world study of palbociclib combined with endocrine therapy for patients with metastatic breast cancer: A comparison of subsequent treatment patterns and HER2 expression analysis
    Liang, Xu
    Zhang, Linhui
    Gui, Xinyu
    Di, Lijun
    Li, Huiping
    Song, Guohong
    CANCER, 2024, 130 : 1476 - 1487
  • [25] Real-World Predictors of Severe Neutropenia Associated with Palbociclib and Endocrine Therapy for Metastatic Breast Cancer in Japanese Patients
    Takada, Shinya
    Maeda, Hideki
    Umehara, Kengo
    Kuwahara, Sayuri
    Yamamoto, Mitsugu
    Tomioka, Nobumoto
    Watanabe, Kenichi
    Mino, Kozo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2023, 46 (08) : 1105 - 1111
  • [26] Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real-World Evidence Analysis
    Feinberg, Bruce
    Kish, Jonathan
    Dokubo, Igoni
    Wojtnek, Jeff
    Gajra, Ajeet
    Lard, Kevin
    ONCOLOGIST, 2020, 25 (04) : 319 - 326
  • [27] Warning factors of metachronous uterine cancer in patients with breast cancer: a real-world nationwide cohort study
    Tai, Yi-Jou
    Lee, Chung-Chen
    Chen, Yong-Chen
    You, San-Lin
    Chiang, Ying-Cheng
    GYNECOLOGIC ONCOLOGY REPORTS, 2025, 59
  • [28] Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study
    Kurvi Patwala
    David Stephen Prince
    Yael Celermajer
    Waafiqa Alam
    Eldho Paul
    Simone Irene Strasser
    Geoffrey William McCaughan
    Paul Gow
    Siddharth Sood
    Elise Murphy
    Stuart Roberts
    Elliot Freeman
    Elizabeth Stratton
    Scott Anthony Davison
    Miriam Tania Levy
    McCawley Clark-Dickson
    Vi Nguyen
    Sally Bell
    Amanda Nicoll
    Ashley Bloom
    Alice Unah Lee
    Marno Ryan
    Jessica Howell
    Zina Valaydon
    Alexandra Mack
    Ken Liu
    Anouk Dev
    Hepatology International, 2022, 16 : 1170 - 1178
  • [29] Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter, observational, real-world study
    Sang, Die
    Su, Yanfang
    Zhang, Yurong
    Guan, Yanfeng
    Fan, Shanmin
    Zhang, Jintao
    Zheng, Lijun
    Wang, Yanling
    Guo, Ying
    Lei, Zixuan
    Li, Man
    Yuan, Peng
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17
  • [30] A real-world study of anlotinib as third-line or above therapy in patients with her-2 negative metastatic breast cancer
    Shao, Yingbo
    Luo, Zhifen
    Yu, Yang
    He, Yaning
    Liu, Chaojun
    Chen, Qi
    Zhu, Fangyuan
    Nie, Bing
    Liu, Hui
    FRONTIERS IN ONCOLOGY, 2022, 12
12345